Nexalin Technology, Inc. (NXL) Financial Statements
Industry: Electromedical & Electrotherapeutic Apparatus
In fiscal 2025, Nexalin Technology reported revenue of $301,647, up 78.8% from $168,721 the year before. Net income was -$8.2M (a -2725.8% net margin), or -$15.00 per diluted share. Gross margin was 79.7% and operating margin was -2781.7%. Operating activities generated -$5.0M of cash. At fiscal year end, Nexalin Technology held $4.6M in total assets against $887,333 in total liabilities, including $654,783 of cash and equivalents.
Open the full interactive Nexalin Technology financials → Quarterly statements, key ratios, valuation history and price charts.
Nexalin Technology Key Stats
| Share Price | $2.64 |
|---|---|
| Market Cap | $1.9M |
| Revenue YoY Growth | +78.8% |
| 52-Week Range | $2.64 – $50.40 |
| Shares Outstanding | 704,764 (basic, 2026 Q2) |
Nexalin Technology Income Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $1.3M | $110,748 | $168,721 | $301,647 |
| Gross Profit | $958,145 | $85,060 | $132,128 | $240,274 |
| Operating Income | -$1.8M | -$5.7M | -$7.8M | -$8.4M |
| Pre-Tax Income | -$1.7M | -$4.6M | -$7.6M | -$8.2M |
| Income Tax | — | — | -$4,851 | $1,048 |
| Net Income | -$1.7M | -$4.6M | -$7.6M | -$8.2M |
| Diluted EPS | — | -$18.90 | -$24.90 | -$15.00 |
Nexalin Technology Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $18,149 | $171,895 | $14,950 | $12,161 |
| Net Income | -$2.3M | -$2.4M | -$2.1M | -$2.2M |
| Diluted EPS | -$3.90 | -$0.14 | -$3.30 | -$3.30 |
Nexalin Technology Balance Sheet
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash & Equivalents | $162,743 | $580,230 | $574,485 | $654,783 |
| Current Assets | $7.4M | $3.4M | $4.0M | $4.3M |
| Total Assets | $7.4M | $3.6M | $4.2M | $4.6M |
| Current Liabilities | $1.9M | $425,281 | $546,694 | $887,333 |
| Total Liabilities | $2.0M | $425,281 | $546,694 | $887,333 |
| Shareholders' Equity | $5.5M | $3.2M | $3.7M | $3.7M |
Nexalin Technology Cash Flow Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash From Operations | -$2.2M | -$3.8M | -$3.9M | -$5.0M |
| Cash From Investing | -$6.8M | $4.5M | -$577,539 | -$131,991 |
| Cash From Financing | $8.5M | -$200,000 | $4.5M | $5.2M |
Figures from Nexalin Technology's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Nexalin Technology financials page for every line item.
Nexalin Technology Company Profile
| Ticker | NXL |
|---|---|
| Exchange | Nasdaq |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Headquarters | Houston, Texas |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001527352 |
Frequently Asked Questions
What was Nexalin Technology's revenue in fiscal 2025?
Nexalin Technology (NXL) reported revenue of $301,647 for fiscal 2025.
What is Nexalin Technology's annual revenue history?
Nexalin Technology's annual revenue by fiscal year: 2022: $1.3M; 2023: $110,748; 2024: $168,721; 2025: $301,647.
What was Nexalin Technology's net income in fiscal 2025?
Nexalin Technology reported net income of -$8.2M for fiscal 2025.
What was Nexalin Technology's earnings per share (EPS) in fiscal 2025?
Nexalin Technology's diluted EPS was -$15.00 for fiscal 2025 (adjusted for any later stock splits).
What was Nexalin Technology's revenue last quarter?
In its most recent reported quarter (2026 Q2), Nexalin Technology reported revenue of $12,161.
How many shares of Nexalin Technology are outstanding?
Nexalin Technology reported a weighted average of 704,764 basic shares outstanding in 2026 Q2.
What is Nexalin Technology's market cap?
Based on its latest closing price, Nexalin Technology (NXL) has a market capitalization of about $1.9M.
When does Nexalin Technology's fiscal year end?
Nexalin Technology's fiscal year end, as registered with the SEC, is December 31.
Where is Nexalin Technology headquartered?
Nexalin Technology lists its business address in Houston, Texas in its SEC filings.
Nexalin Technology Competitors & Similar Companies
See all 23 Electromedical & Electrotherapeutic Apparatus companies →